We therefore tested 5 different anti-tumor compounds, including decitabine (demethylating), depsipeptide (histone deacetylase inhibitor), selumitinib (MEK inhibitor), and AZD 5438 and flavopiridol (multi-CDK inhibitors) (Table 4). The gene discussed is MAP2K7; the disease is neoplasm.